Investigator barriers and preferences to conduct clinical drug trials in Finland: A qualitative study

Pharmacy World and Science

Volumn 25, Issue 6, 2003, Pages 251-259

  Keinonen, Tuija ^a,b   Keränen, Tapani ^c,d   Klaukka, Timo ^e   Saano, Veijof ^f   Ylitalo, Pauli ^g   Enlund, Hannes ^a,h  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Oy Medfiles Ltd   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e SOCIAL INSURANCE INSTITUTION   (Finland)

^f NATIONAL AGENCY FOR MEDICINES   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Barriers; Clinical trials; Drugs; Finland; GCP; Investigational; Investigator preference; Qualitative study

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG RESEARCH; EXPERIENCE; FEMALE; FINLAND; GOOD CLINICAL PRACTICE; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MOTIVATION; NORMAL HUMAN; PHYSICIAN ATTITUDE; POSTGRADUATE EDUCATION;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; DRUG INDUSTRY; DRUGS, INVESTIGATIONAL; FINLAND; HOSPITALS, UNIVERSITY; HUMANS; MOTIVATION; RESEARCH PERSONNEL;

EID: 0345095319     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000006517.36241.a5     Document Type: Article

References (43)

1. ICH Harmonised Tripartite Guideline for Good Clinical Practice, 2nd ed. Richmond, UK: Brookwood Medical Publications, 1997.
2. Bohaychuk W, Ball G, Lawrence G, Sotirov K. A quantitative view of international GCP compliance. Appl Clin Trials 1998; 7 (2): 24-9.
3. Brunier DP, Nahler GR. GCP Deficiencies in clinical trials in Western and Eastern Europe. Appl Clin Trials 1998; 7(3):46-51.
4. Bohaychuk W, Ball G, Lawrence G, Sotirov K. A qualitative view of international compliance. Appl Clin Trials 1998; 7(4): 26-35.
5. Gamache V. FDA complaints against investigative sites still rising. CenterWatch 2001; 8(1): 11-5.
6. Bohaychuk W, Ball G, Lawrence G, Sotirov K. Protocol content and management. Appl Clin Trials 1999; 8(3): 67-77.
7. Ward E, King M, Lloyd M, Bower P, Friedli K. Conducting randomized trials in general practice: methodological and practical issues. Br J Gen Pract 1999; 49: 919-22.
8. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999; 52: 1143-56.
9. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomised clinical trial of surgery for breast cancer. N Engl J Med 1984; 310: 1363-7.
10. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Contr Clin Trials 1997; 18: 328-57.
11. Tognoni G, Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, et al. Randomised clinical trials in general practice: lessons from a failure. BMJ 1991; 303: 969-71.
12. van der Windt D, Koes BW, van Aarst M, Heemskerk M, Bouter LM. Practical aspects of conducting a pragmatic randomised trial in primary care: patient recruitment and outcome assessment. Br J Gen Pract 2000; 50: 371-4.
13. Langley C, Gray S, Selley S, Bowie C, Price C. Clinicians' attitudes to recruitment to randomised trials in cancer care: a qualitative study. J Health Serv Res Policy 2000; 5: 164-9.
14. Brittain-Dissont T. SMOs - more letters from America. Helix 2001; May 10-1.
15. Glass HE, Kane RA. Why investigators take part in clinical trials? Appl Clin Trials 2000; 9(6): 46-54.
16. Anonymous. Investigator scrutiny and certification. ACRP 2001 White Paper. Monitor 2001; 15(2): 26-31.
17. Gwede CK, Johnson D, Trotti A. Measuring the workload of clinical research coordinators. Part I, tools to study workload issues. Appl Clin Trials 2000; 9(1): 40-4.
18. Szpindor SA. Current regulatory considerations and challenges for the clinical investigative sites. Monitor 2000; 14(4): 35-42.
19. Donato BJ, Gibson TR. Clinical trials in the USA. GCP Journal 2001; 8:14-21.
20. Pharmaceutical Information Centre. Clinical Trials in Finland 1999. Helsinki: Libris, 1999.
21. Keinonen T, Nieminen S, Saareks V, Miettinen P, Saano V, Ylitalo P. The quality and characteristics of clinical drug study notifications reviewed by the regulatory agency in Finland. Contr Clin Trials 2002; 2: 42-51.
22. National Agency for Medicines and Social Insurance Institution. Finnish Statistics on Medicines 2000. Helsinki: Edita, 2001.
23. Pharma Industry of Finland. Kliiniset Iääketutkimukset Suomessa 2001. [Clinical Trials in Finland 2001.] (Annual query for statistics). Helsinki: Pharma Industry of Finland, 2002.
24. Krippendorff K. Content Analysis. An Introduction to Its Methodology. Beverly Hills, California: Sage Publications, 1986.
25. Strauss A, Corbin J. Basics of qualitative research. Techniques and Procedures for Developing Grounded Theory, 2nd ed. Thousand Oaks, California: Sage Publications, 1998.
26. Green J. Commentary: grounded theory and the constant comparative method. BMJ 1998; 316: 1064-5.
27. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995; 311:42-5.
28. Pope C, Ziebland S, Mays N. Analysing qualitative data. BMJ 2000;320:114-6.
29. Zisson S. Large site networks quietly take the field. CenterWatch 2001; 8(1): 4-7.
30. Schuster DP, McGill J. Attract clinical trials to an AMC. Appl Clin Trials 2001; 10 (11): 44-52.
31. Nathan DG. Clinical research: perceptions, reality, and proposed solutions. NIH director's panel on clinical research. JAMA 1998; 280:1427-31.
32. Rosenberg L. Physician-Scientists - endangered and essential. Science 1999; 283: 331-2.
33. Bodenheimer T. Uneasy alliance - clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342: 1539-44.
34. Newman TJ. Clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 343: 510-1.
35. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Nat Cancer Inst 1995; 87: 1747-59.
36. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Contr Clin Trials 1987; 8 (4 Suppl): 6S-30S.
37. Bonner J. Taking on development delays. CenterWatch-Europe 2002; 2(1): 9-14.
38. Allen W. European CROs muscle into the study conduct services market. CenterWatchEurope 2001; 1(4): 4-10.
39. Peters J. AMCs finding and fueling growth. CenterWatch 2001; 8(1): 8-12.
40. Hyppölä H, Virjo I, Mattila K, Kumpusalo E, Kujala S, Hilla H et al. Lääkäri 98. [Physician 98.] [Report on a questionnaire study about Finnish physicians graduated in 1987-1996 and comparison with the situations ten and five years earlier.] Publications of the Finnish Ministry of Social Affairs and Health, 2000: 10. Helsinki: Edita, 2000.
41. Hyppölä H, Kumpusalo E, Neittaanmäki L, Mattila K, Virjo I, Kujala S. Where should special attention be paid in undergraduate medical education? Two surveys among Finnish doctors. Med Educ 1996; 30: 31-7.
42. Editorial. Researcher, clinician, or a teacher? Lancet 2001; 357(9268): 1543.
43. Saukko P, Andersson L, Ihalainen J, Mattila K, Halila H. Tiedepoliittisen työryhmän muistio 1996. [Memorandum of the Science Policy Committee 1996.] Helsinki: Finnish Medical Association, 1996.